Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurotrophin 3 | 9 | 2018 | 12 | 1.900 |
Why?
|
| Spinal Cord Injuries | 6 | 2014 | 305 | 1.230 |
Why?
|
| Nerve Regeneration | 8 | 2013 | 86 | 1.180 |
Why?
|
| Neuronal Plasticity | 6 | 2014 | 274 | 0.990 |
Why?
|
| Axons | 8 | 2013 | 380 | 0.810 |
Why?
|
| Genetic Vectors | 18 | 2015 | 935 | 0.720 |
Why?
|
| Growth Cones | 4 | 2013 | 17 | 0.680 |
Why?
|
| Nerve Growth Factors | 5 | 2007 | 72 | 0.630 |
Why?
|
| Rats | 21 | 2018 | 3631 | 0.610 |
Why?
|
| Adenoviridae | 11 | 2015 | 605 | 0.560 |
Why?
|
| Thymidine Kinase | 8 | 2002 | 88 | 0.530 |
Why?
|
| Central Nervous System | 4 | 2006 | 253 | 0.520 |
Why?
|
| Pyramidal Tracts | 5 | 2015 | 36 | 0.510 |
Why?
|
| Wallerian Degeneration | 1 | 2013 | 8 | 0.440 |
Why?
|
| Neuroimmunomodulation | 1 | 2013 | 16 | 0.440 |
Why?
|
| Cerebral Cortex | 3 | 2006 | 434 | 0.430 |
Why?
|
| Gene Transfer Techniques | 4 | 2002 | 355 | 0.420 |
Why?
|
| Motor Neurons | 4 | 2007 | 138 | 0.420 |
Why?
|
| Spinal Cord | 7 | 2015 | 293 | 0.420 |
Why?
|
| Th2 Cells | 1 | 2013 | 187 | 0.410 |
Why?
|
| Nerve Tissue Proteins | 5 | 1998 | 1117 | 0.380 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2013 | 1211 | 0.380 |
Why?
|
| Ganciclovir | 7 | 2002 | 96 | 0.370 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2006 | 118 | 0.350 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2009 | 63 | 0.330 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 60 | 0.330 |
Why?
|
| Transduction, Genetic | 6 | 2009 | 288 | 0.310 |
Why?
|
| Neurons | 4 | 2006 | 1927 | 0.310 |
Why?
|
| Simplexvirus | 6 | 2000 | 99 | 0.300 |
Why?
|
| Protein Kinases | 1 | 2009 | 330 | 0.300 |
Why?
|
| Genetic Therapy | 6 | 2008 | 673 | 0.290 |
Why?
|
| Immunohistochemistry | 8 | 2013 | 1684 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 491 | 0.280 |
Why?
|
| Animals | 32 | 2018 | 33740 | 0.280 |
Why?
|
| Raphe Nuclei | 1 | 2005 | 18 | 0.260 |
Why?
|
| Recovery of Function | 2 | 2018 | 437 | 0.240 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 5 | 2008 | 22 | 0.230 |
Why?
|
| Bone Marrow Cells | 2 | 2003 | 258 | 0.230 |
Why?
|
| Sciatic Nerve | 4 | 2003 | 54 | 0.230 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2006 | 576 | 0.220 |
Why?
|
| Brain Neoplasms | 6 | 2007 | 1217 | 0.220 |
Why?
|
| Avian Sarcoma Viruses | 4 | 2000 | 28 | 0.220 |
Why?
|
| Brain | 4 | 2013 | 2947 | 0.210 |
Why?
|
| Myelin Sheath | 3 | 1993 | 132 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2003 | 537 | 0.190 |
Why?
|
| Nerve Growth Factor | 3 | 2007 | 24 | 0.190 |
Why?
|
| Mice, Neurologic Mutants | 2 | 1992 | 74 | 0.180 |
Why?
|
| Myelin Basic Protein | 2 | 1992 | 69 | 0.180 |
Why?
|
| Disease Models, Animal | 5 | 2014 | 4268 | 0.180 |
Why?
|
| Flow Cytometry | 3 | 2013 | 804 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 3 | 2006 | 394 | 0.170 |
Why?
|
| Brain Diseases | 2 | 2005 | 294 | 0.170 |
Why?
|
| Stroke | 2 | 2018 | 958 | 0.160 |
Why?
|
| Cell Differentiation | 3 | 2007 | 1916 | 0.160 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2002 | 243 | 0.160 |
Why?
|
| Defective Viruses | 1 | 1997 | 17 | 0.140 |
Why?
|
| Biotin | 2 | 2007 | 41 | 0.140 |
Why?
|
| Dextrans | 2 | 2007 | 46 | 0.140 |
Why?
|
| Locomotion | 2 | 2015 | 69 | 0.140 |
Why?
|
| Epithelium, Corneal | 2 | 2008 | 172 | 0.130 |
Why?
|
| Antimetabolites | 1 | 1996 | 32 | 0.130 |
Why?
|
| p-Chloroamphetamine | 2 | 2006 | 3 | 0.130 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 80 | 0.130 |
Why?
|
| Mastadenovirus | 1 | 1995 | 1 | 0.130 |
Why?
|
| Viral Proteins | 1 | 1997 | 348 | 0.120 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1995 | 68 | 0.120 |
Why?
|
| Chick Embryo | 2 | 2009 | 132 | 0.120 |
Why?
|
| Serotonin | 2 | 2006 | 222 | 0.120 |
Why?
|
| Adoptive Transfer | 2 | 2013 | 237 | 0.120 |
Why?
|
| beta-Galactosidase | 4 | 2002 | 143 | 0.110 |
Why?
|
| Rats, Nude | 1 | 2013 | 5 | 0.110 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2013 | 61 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 44 | 0.110 |
Why?
|
| Peripheral Nerve Injuries | 1 | 1993 | 33 | 0.110 |
Why?
|
| Cell Survival | 4 | 2008 | 803 | 0.110 |
Why?
|
| Glioma | 2 | 1994 | 491 | 0.110 |
Why?
|
| Rats, Inbred F344 | 4 | 2002 | 102 | 0.110 |
Why?
|
| Schwann Cells | 1 | 1993 | 59 | 0.110 |
Why?
|
| Microscopy, Confocal | 3 | 2009 | 348 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2007 | 1167 | 0.100 |
Why?
|
| Female | 13 | 2018 | 65427 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 515 | 0.090 |
Why?
|
| Limbus Corneae | 2 | 2007 | 33 | 0.090 |
Why?
|
| Nerve Net | 1 | 2013 | 236 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1294 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2009 | 1102 | 0.090 |
Why?
|
| Antiviral Agents | 4 | 2002 | 740 | 0.080 |
Why?
|
| RNA, Messenger | 5 | 2007 | 2820 | 0.080 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2007 | 13 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 1992 | 2391 | 0.080 |
Why?
|
| Biomedical Engineering | 1 | 2008 | 30 | 0.080 |
Why?
|
| HeLa Cells | 2 | 2003 | 809 | 0.080 |
Why?
|
| Facial Nerve | 2 | 1998 | 25 | 0.080 |
Why?
|
| Facial Muscles | 2 | 1998 | 33 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 1995 | 991 | 0.080 |
Why?
|
| Time Factors | 4 | 2018 | 6201 | 0.080 |
Why?
|
| Stem Cells | 3 | 2008 | 701 | 0.070 |
Why?
|
| Nerve Crush | 3 | 1998 | 11 | 0.070 |
Why?
|
| Receptor, trkA | 1 | 2007 | 16 | 0.070 |
Why?
|
| Injections, Intramuscular | 2 | 2018 | 192 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 428 | 0.070 |
Why?
|
| Microglia | 1 | 2007 | 95 | 0.070 |
Why?
|
| Serotonin Agents | 1 | 2006 | 14 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 291 | 0.070 |
Why?
|
| Signal Transduction | 1 | 1998 | 4508 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2007 | 420 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1011 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2005 | 56 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2005 | 264 | 0.060 |
Why?
|
| Gene Expression | 3 | 2007 | 1569 | 0.060 |
Why?
|
| Receptor, ErbB-2 | 1 | 2007 | 495 | 0.060 |
Why?
|
| Medulloblastoma | 1 | 2007 | 338 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 645 | 0.060 |
Why?
|
| Transfection | 1 | 2005 | 1068 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2007 | 2533 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 157 | 0.050 |
Why?
|
| Acute Disease | 1 | 2006 | 1090 | 0.050 |
Why?
|
| Mice | 8 | 2013 | 17497 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2015 | 939 | 0.050 |
Why?
|
| Cobra Cardiotoxin Proteins | 1 | 2002 | 5 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 868 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2003 | 149 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2003 | 153 | 0.050 |
Why?
|
| Cornea | 1 | 2007 | 646 | 0.050 |
Why?
|
| Biological Transport | 1 | 2003 | 347 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2003 | 238 | 0.050 |
Why?
|
| Neurites | 1 | 2001 | 44 | 0.050 |
Why?
|
| Dependovirus | 1 | 2002 | 130 | 0.050 |
Why?
|
| Ganglia, Spinal | 1 | 2001 | 73 | 0.050 |
Why?
|
| Software | 1 | 2006 | 677 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2007 | 804 | 0.050 |
Why?
|
| Cell Communication | 1 | 2001 | 165 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 779 | 0.040 |
Why?
|
| Survival Rate | 2 | 1995 | 1995 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 576 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2007 | 462 | 0.040 |
Why?
|
| Memory | 1 | 2002 | 360 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 2007 | 382 | 0.040 |
Why?
|
| Sensorimotor Cortex | 1 | 2018 | 9 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2851 | 0.040 |
Why?
|
| Algorithms | 1 | 2006 | 1597 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2007 | 966 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2002 | 482 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 1678 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 1063 | 0.040 |
Why?
|
| Radiography | 2 | 2000 | 818 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 423 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 1997 | 87 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 1997 | 80 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 1997 | 51 | 0.040 |
Why?
|
| Pons | 1 | 1997 | 32 | 0.040 |
Why?
|
| Sigmodontinae | 1 | 1997 | 41 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 86 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2003 | 4352 | 0.030 |
Why?
|
| Ciliary Neurotrophic Factor | 2 | 1993 | 10 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1996 | 99 | 0.030 |
Why?
|
| Brain Injuries | 1 | 2002 | 734 | 0.030 |
Why?
|
| Papio | 1 | 1996 | 59 | 0.030 |
Why?
|
| Virus Shedding | 1 | 1996 | 79 | 0.030 |
Why?
|
| Microinjections | 1 | 2015 | 52 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2003 | 12102 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1997 | 146 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 1996 | 237 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2015 | 39 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1996 | 423 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 1338 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2000 | 1684 | 0.030 |
Why?
|
| Forelimb | 1 | 2014 | 14 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 1998 | 991 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 1 | 1994 | 14 | 0.030 |
Why?
|
| Denervation | 1 | 2014 | 29 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 369 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1996 | 477 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 1586 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3518 | 0.030 |
Why?
|
| Brain Stem | 1 | 2014 | 115 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 1194 | 0.030 |
Why?
|
| Receptor, EphA4 | 1 | 2013 | 3 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 367 | 0.030 |
Why?
|
| Ephrin-B3 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 1993 | 84 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 126 | 0.030 |
Why?
|
| Pia Mater | 1 | 1992 | 9 | 0.030 |
Why?
|
| Median Eminence | 1 | 1992 | 5 | 0.030 |
Why?
|
| Choroid Plexus | 1 | 1992 | 22 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2015 | 332 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 1515 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 1992 | 78 | 0.030 |
Why?
|
| Cerebral Ventricles | 1 | 1992 | 80 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1992 | 104 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2008 | 3050 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 126 | 0.020 |
Why?
|
| Humans | 9 | 2015 | 123190 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 310 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 391 | 0.020 |
Why?
|
| Macrophages | 1 | 1994 | 607 | 0.020 |
Why?
|
| Optic Nerve | 1 | 1992 | 117 | 0.020 |
Why?
|
| Reference Values | 1 | 1992 | 696 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 1133 | 0.020 |
Why?
|
| Astrocytes | 1 | 1992 | 250 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1992 | 424 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 1990 | 84 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2801 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2698 | 0.020 |
Why?
|
| Corneal Transplantation | 1 | 2008 | 48 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2007 | 5 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3871 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 6 | 0.020 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2007 | 105 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 187 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2007 | 211 | 0.020 |
Why?
|
| Male | 5 | 2014 | 60020 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 678 | 0.020 |
Why?
|
| Seizures | 1 | 1990 | 871 | 0.010 |
Why?
|
| Genotype | 1 | 1990 | 2548 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 671 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2002 | 65 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 40 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2002 | 21 | 0.010 |
Why?
|
| Methylnitrosourea | 1 | 2002 | 19 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2002 | 48 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2002 | 56 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 262 | 0.010 |
Why?
|
| Laminin | 1 | 2001 | 59 | 0.010 |
Why?
|
| Carcinogens | 1 | 2002 | 153 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2001 | 93 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 1284 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2001 | 234 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2001 | 123 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2001 | 271 | 0.010 |
Why?
|
| Collagen | 1 | 2001 | 313 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 330 | 0.010 |
Why?
|
| Gliosarcoma | 1 | 2000 | 9 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2001 | 294 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 2308 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1528 | 0.010 |
Why?
|
| Astrocytoma | 1 | 2000 | 102 | 0.010 |
Why?
|
| Prostate | 1 | 2001 | 421 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2002 | 619 | 0.010 |
Why?
|
| Biomarkers | 1 | 2007 | 2943 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2000 | 860 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 997 | 0.010 |
Why?
|
| Aged | 2 | 2008 | 19068 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2000 | 1240 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2000 | 333 | 0.010 |
Why?
|
| Middle Aged | 2 | 2008 | 25976 | 0.010 |
Why?
|
| Young Adult | 1 | 2008 | 8868 | 0.010 |
Why?
|
| Incidence | 1 | 2002 | 3050 | 0.010 |
Why?
|
| Adult | 2 | 2008 | 29035 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1994 | 691 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1992 | 28 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 224 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 258 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 469 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1992 | 769 | 0.000 |
Why?
|